HG Birnbaum

815 total citations
27 papers, 627 citations indexed

About

HG Birnbaum is a scholar working on Psychiatry and Mental health, General Health Professions and Economics and Econometrics. According to data from OpenAlex, HG Birnbaum has authored 27 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in General Health Professions and 3 papers in Economics and Econometrics. Recurrent topics in HG Birnbaum's work include Health Systems, Economic Evaluations, Quality of Life (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Asthma and respiratory diseases (2 papers). HG Birnbaum is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (2 papers), Pharmacological Effects and Toxicity Studies (2 papers) and Asthma and respiratory diseases (2 papers). HG Birnbaum collaborates with scholars based in United States, Netherlands and Mexico. HG Birnbaum's co-authors include RC Kessler, I. Hwang, Victoria Shahly, Evelyn J. Bromet, Nancy A. Sampson, Theodore L. Sourkes, K.E. Lloyd, Moussa B. H. Youdim, Gregory Gregoriadis and PE Greenberg and has published in prestigious journals such as Psychological Medicine, Journal of Adolescent Health and Value in Health.

In The Last Decade

HG Birnbaum

25 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
HG Birnbaum United States 7 117 115 114 98 76 27 627
Raquel Crider United States 8 102 0.9× 90 0.8× 147 1.3× 41 0.4× 90 1.2× 14 552
Chi-Un Pae United States 9 68 0.6× 106 0.9× 144 1.3× 67 0.7× 130 1.7× 11 560
Guk Hee Suh South Korea 8 53 0.5× 151 1.3× 129 1.1× 111 1.1× 234 3.1× 10 554
Carolyn Coulson Australia 10 102 0.9× 93 0.8× 184 1.6× 74 0.8× 119 1.6× 10 643
Annelise A. Madison United States 16 120 1.0× 67 0.6× 168 1.5× 69 0.7× 117 1.5× 48 859
Yulong Lian China 16 96 0.8× 103 0.9× 113 1.0× 86 0.9× 173 2.3× 53 814
Kedar Manandhar Nepal 15 65 0.6× 296 2.6× 127 1.1× 73 0.7× 68 0.9× 26 664
Andrés Herrán Spain 15 243 2.1× 381 3.3× 293 2.6× 55 0.6× 108 1.4× 30 828
Yuhua Liao China 13 94 0.8× 60 0.5× 316 2.8× 52 0.5× 79 1.0× 45 824
Cláudio E. M. Banzato Brazil 16 77 0.7× 280 2.4× 186 1.6× 25 0.3× 95 1.3× 70 765

Countries citing papers authored by HG Birnbaum

Since Specialization
Citations

This map shows the geographic impact of HG Birnbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by HG Birnbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites HG Birnbaum more than expected).

Fields of papers citing papers by HG Birnbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by HG Birnbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by HG Birnbaum. The network helps show where HG Birnbaum may publish in the future.

Co-authorship network of co-authors of HG Birnbaum

This figure shows the co-authorship network connecting the top 25 collaborators of HG Birnbaum. A scholar is included among the top collaborators of HG Birnbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with HG Birnbaum. HG Birnbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shei, Amie, et al.. (2015). Description of Prophylactic drug utilization Patterns in Migraine Patients. Value in Health. 18(3). A285–A285. 2 indexed citations
2.
Hadjiyianni, Irene, et al.. (2015). Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation Among People With Type 2 Diabetes Mellitus In Japan. Value in Health. 18(7). A611–A612. 8 indexed citations
3.
Rice, J. Bradford, Urvi Desai, Alice Kate G. Cummings, et al.. (2013). Medical, Drug, And Work-Loss Costs Of Venous Leg Ulcers. Value in Health. 16(3). A73–A73. 4 indexed citations
4.
Kessler, RC, HG Birnbaum, Evelyn J. Bromet, et al.. (2009). Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R). Psychological Medicine. 40(2). 225–237. 389 indexed citations
5.
Ivanova, Jasmina, HG Birnbaum, M. Schiller, et al.. (2009). PSY31 REAL-WORLD USE OF DULOXETINE FOR LOW BACK PAIN. Value in Health. 12(3). A135–A136. 2 indexed citations
6.
Birnbaum, HG, Jasmina Ivanova, Yohanne Kidolezi, & Sue Caleo. (2008). PND15 THE INDIRECT COST BURDEN OF EPILEPSY IN THE UNITED STATES. Value in Health. 11(6). A604–A604. 1 indexed citations
7.
Birnbaum, HG, Jasmina I. Ivanova, Yohanne Kidolezi, & Sue Caleo. (2008). PND11 EPILEPSY COST OF ILLNESS IN THE U.S. PRIVATELY INSURED. Value in Health. 11(6). A602–A603. 1 indexed citations
8.
Birnbaum, HG, et al.. (2008). PND22 THE COST OF DISABILITY AND MEDICALLY-RELATED ABSENTEEISM AMONG EMPLOYEES WITH MULTIPLE SCLEROSIS. Value in Health. 11(3). A143–A143. 2 indexed citations
9.
Birnbaum, HG, et al.. (2007). PAR2 COST OF PAIN THERAPY FOR OSTEOARTHRITIS IN A PRIVATELY INSURED POPULATION IN THE UNITED STATES. Value in Health. 10(3). A117–A117. 1 indexed citations
11.
Birnbaum, HG, et al.. (2004). PMH33 DRUG TREATMENT PATTERNS OF BIPOLAR DISORDER AND ASSOCIATED COSTS. Value in Health. 7(3). 273–273. 1 indexed citations
13.
Swensen, Andrine R., et al.. (2004). Incidence and costs of accidents among attention-deficit/hyperactivity disorder patients. Journal of Adolescent Health. 35(4). 346.e1–346.e1. 47 indexed citations
14.
Saha, Atanu, et al.. (2003). PHP24: GENERIC COMPETITION IN THE PHARMACEUTICAL INDUSTRY. Value in Health. 6(3). 207–207. 1 indexed citations
15.
Birnbaum, HG. (2003). Lifetime medical costs for women: cardiovascular disease, diabetes, and stress urinary incontinence. Women s Health Issues. 13(6). 204–213. 11 indexed citations
16.
Greenberg, PE, et al.. (2003). PMH37: THE ECONOMIC BURDEN OF DEPRESSION IN 2000. Value in Health. 6(3). 356–356. 1 indexed citations
17.
Barghout, Victoria, et al.. (2002). PGI7 ECONOMIC OUTCOMES OF EMPLOYER BENEFICIARIES TREATED FOR IRRITABLE BOWEL SYNDROME (IBS). Value in Health. 5(3). 252–253. 1 indexed citations
18.
Corey‐Lisle, Patricia K., et al.. (2001). PMH19: IDENTIFICATION AND ONE-YEAR COSTS OF TREATMENT-RESISTANT DEPRESSION IN A CLAIMS DATA ANALYSIS. Value in Health. 4(6). 458–458. 1 indexed citations
19.
Birnbaum, HG, et al.. (1975). [Incidence of the Blastomyces and Trichomonad infections during the use of hormonal and intrauterine contraception].. PubMed. 97(26). 1636–40. 5 indexed citations
20.
Sourkes, Theodore L., K.E. Lloyd, & HG Birnbaum. (1968). Inverse relationship of hepatic copper and iron concentrations in rats fed deficient diets. Canadian Journal of Biochemistry. 46(3). 267–271. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026